THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS

Více o knize

Focusing on innovative cancer treatment, the book presents two groundbreaking drug compounds, PT162 and PT167, developed to exploit the Warburg effect in cancer cells. Both drugs demonstrate remarkable efficacy, completely halting cancer cell growth and inducing apoptosis through the reactivation of p53 function. PT162, a novel compound, and PT166, a new colchicinoid derivative, were combined to create PT167, which effectively targets a wide range of cancer types, including leukemia. The author details the synthesis and testing results, proposing a new strategy for cancer therapy.